GE HealthCare has a credible earnings delivery track record — three beats in the prior three quarters before the most recent miss — and a favorable risk/reward of roughly 2.1-to-1 with approximately 11% room to the analyst-derived target, but the stock is in a confirmed technical downtrend with a death cross in place and growth is soft, making the setup one that rewards patience until the chart stabilizes.
Thesis pillars
- Earnings Delivery Record↑Improving
- Confirmed Technical Downtrend↓Deteriorating
- Favorable Risk Reward Setup↓Deteriorating
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 4, 2026· older than 90 days
GE HealthCare Technologies Inc. (GEHC) Stock Analysis
Recovery setup
Healthcare · Medical Devices
Hold if already holding. Not a fresh buy at $80.66, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Overbought (RSI 84).
GE HealthCare Technologies manufactures medical imaging systems (CT, MR, X-ray, ultrasound, molecular imaging), patient monitoring devices, and pharmaceutical diagnostic agents — contrast media and radiopharmaceuticals — sold to hospitals and health systems in over 160 countries... Read more
Hold if already holding. Not a fresh buy at $80.66, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Overbought (RSI 84). Chart setup: Death cross but MACD improving, RSI 84. Maintain position. Not compelling to add more. Score 6.1/10, moderate confidence.
Passes 6/9 gates (positive momentum, clean insider activity, news boost analyst 0.40, earnings proximity 91d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated Oct 28, 2026Recent Developments — GE HealthCare Technologies Inc.
Latest news
- NEWS GE HealthCare Technologies Inc. Stock 12‑Month Price Target Raised to $83.58, Implies 18% Upside - TradingView — TradingView Oct 28, 2026 positive
- NEWS Is It Too Late to Buy GE HealthCare Technologies Inc (GEHC) After 6.6% Rally? GF Value Says Undervalued - GuruFocus — GuruFocus Oct 28, 2026 positive
- NEWS GE HealthCare Technologies Inc. stock falls Wednesday, underperforms market - MarketWatch — MarketWatch Sep 30, 2026 negative
- NEWS GE HealthCare Technologies Inc (GEHC) Stock Up 12.2% and Still U - GuruFocus — GuruFocus Jul 29, 2026 positive
- NEWS GE HealthCare Stock Soars After Earnings—and It’s Suddenly the Best Performing GE - Barron's — Barron's Jul 29, 2026 positive
Latest item Oct 28, 2026 · Generated 2026-11-04T11:39:49Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMGeographicoutside the U.S.10-K Item 1A: 'We generate the majority of our revenue outside of the U.S.'
Material Events(8-K, last 90d)
- 2026-03-17Item 5.02LOWKevin A. Lobo appointed to GE HealthCare Board of Directors and Talent, Culture, and Compensation Committee, effective March 13, 2026. New board appointment; no director departed. No arrangement with any other person cited as basis for selection.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $80.66, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Overbought (RSI 84). Chart setup: Death cross but MACD improving, RSI 84. Maintain position. Not compelling to add more. Analyst target $79.06 reached (−2.0%), stop $76.04 (−6.1%), A.R:R -0.1:1. Score 6.1/10, moderate confidence.
Analyst target $79.06 reached (−2.0% from $80.66); no take-profit level is published. Analyst target $79.06 reached (−2.0%), stop $76.04 (−6.1%), A.R:R -0.1:1. Stop-loss: $76.04.
Analyst target reached - limited upside remaining; Overbought (RSI 84).
GE HealthCare Technologies Inc. trades at a P/E of 17.1 (forward 14.7). TrendMatrix value score: 6.1/10. Verdict: Hold.
29 analysts rate GEHC, with a consensus score of 4.0/5. 20 analysts publish price targets averaging $88.
What does GE HealthCare Technologies Inc. do?GE HealthCare Technologies manufactures medical imaging systems (CT, MR, X-ray, ultrasound, molecular imaging), patient...
GE HealthCare Technologies manufactures medical imaging systems (CT, MR, X-ray, ultrasound, molecular imaging), patient monitoring devices, and pharmaceutical diagnostic agents — contrast media and radiopharmaceuticals — sold to hospitals and health systems in over 160 countries across four segments. Revenue comes from equipment sales, service contracts, consumables, and AI-enabled software, supported by approximately 54,000 employees with 32% in the United States.